会社案内 - 世界のミルテニーバイオテク - 北アメリカ - Gaithersburg

(Gaithersburg)

Gaithersburg
Based in Gaithersburg, MD, Lentigen Technology, Inc. develops and commercializes therapeutics leveraging lentiviral vectors (LV) for numerous areas, including stem cell therapies and chimeric antigen receptor (CAR)-modified T cells for oncology indications. The new 5000 sq. ft. GMP manufacturing facility produces preclinical (non-GMP) and clinical (GMP) lentiviral vectors in two parallel ISO 7 (Class 10,000) Suites and one ISO 8 (Class 100,000) Suite. The suites, which meet US FDA and EU regulatory requirements, are designed for production of clinical grade lentiviral vectors for Phase I and Phase II clinical trials. Lentigen Technology, Inc. also offers contract manufacturing.
Lentigen Technology, Inc.
910 Clopper Road, Suite 200 S
20878 Gaithersburg, MD, USA
Phone +1 617 218 0030
Fax +1 617 218-0050
Email: macs@miltenyibiotec.com

Contact

Miltenyi Biotec K.K.
TEL +81 3 5646 8910
FAX+81 3 5646 8911
macs@miltenyibiotec.jp
お問い合わせ

Product finder

Antibody panel builder

Toolbox

Loading...

Change country

Please select your country to continue